FDA Investigator Aaron F Coleman
Aaron F Coleman has conducted inspections on 86 sites in 5 countries as of 12 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
86
Last Inspection Date:
12 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Trinidad and Tobago,
Thailand,
Dominican Republic,
Barbados
FDA Investigators that have inspected at least one site in common with Aaron F Coleman:
Adriana D Perez,
Alexander B Anderson,
Althea A Williams,
Alysia M Salonia,
Anabel Veiga,
Angela F Orozco,
Angelica M Hernandez,
Benita C Okeke,
Bill Tacket, Jr,
Billy M Battles,
Brian M Campbell,
Brian M Carril,
CDR Ileana Barreto Pettit,
CDR Sean T Creighton,
Charles S Watson,
Christopher T Smith,
Cindy Laboy,
Clara E Santiago,
Craig A Garmendia,
Dawn M Mccabe,
Dawne M Hines,
Derek J Dodd,
Diane L Kelsch,
Dillard H Woody, Jr,
Dionne D Arline,
Earl Echon,
Eduardo Carbonell,
Edwin J Gorney,
Eric C Nielsen,
Eric R Holm,
Facundo I Bernal,
Frank Flores,
Gabriel E Muniz,
Gina Eng,
Giovanna Serpa,
Glenn S Quintanilla,
Heather M Bullock,
Hector Vallellanes,
Isis V Bermudez,
Ivis L Negron,
Ivonne A Vicente,
Jacqueline E Manjone,
James P Stallings,
James To Neal,
Jason D Tenney,
Jason P Aun,
Jennifer L Huntington,
Jennifer Lalama,
Jennifer M Menendez,
Joanne E King,
John J Bernal,
Jordan M Williamson,
Jose Perez Soto,
Karen M Rodriguez,
Karl D Hezel,
Katherine M Taylor,
Katherine V Serrano,
Kelly M Byers,
Kyle S Hobson,
Laura M Lopez,
LCDR Angelica M Chica,
Leslin M Coachman,
Lisa A Warner,
Lissette Paiz,
Marc Balzarini,
Maria D Jiron,
Marinee Flores Marrero,
Matthew B Thomaston,
Megan T Ziegler,
Melinda B Lewis,
Mendoza,
Michael C Lombardi,
Nicole M Bell,
Omayra Nrodriguez Ruiz,
Ormond,
Pablo Alcantara,
Rachel A Peters,
Ramon H Pabon Aponte,
Raymond A Lyn, Jr,
Reynolds,
Rina Bhikha,
Robert W Calais,
Rozelle G Smith,
Ruth A Williams,
Sally Gopaul,
Salvatore N Randazzo,
Sarah E Mcmullen,
Scott R Izyk,
Sharon Giamberini,
Sheila P Barthelemy,
Sophia A Sands,
Stacey A Meyer,
Stacey L Witherwax,
Suzanne A Lovelady,
Teresa I Navas,
Timothy A Tennell,
Valerie C Reed,
Wayne L Jefferson,
William A Oetting,
Yazmith Guzman
Aaron F Coleman's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| September, 2019 | FDA 483 | Florida Smoked Fish, LLC - Form 483, 2019-09-25 |
| November, 2022 | FDA 483 | American Spice Trading Company - Form 483, 2022-11-01 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more